Written question asked by Caroline Lucas (Green Party) on Thursday, 20 October 2016, in the House of Commons. It was due for an answer on Monday, 24 October 2016. It was answered by Baroness Blackwood of North Oxford (Conservative) on Friday, 28 October 2016 on behalf of the Department of Health.
Cannabidiol
- Question
-
To ask the Secretary of State for Health, whether he has had any discussions with the Home Secretary on the Medicines and Healthcare Products Regulatory Agency's (MHRA) review of the classification of products containing cannabidiol since the MHRA's news story on that review was published on 13 October 2016.
- Answer
-
There have been no discussions at Ministerial level but officials from the Medicines and Healthcare products Regulatory Agency (MHRA) and the Home Office have been in contact regarding this issue.
At present, the MHRA has offered an opinion that products containing cannabidiol used for medical purposes should be regulated as medicinal products. If manufacturers do not accept this, the MHRA can use a statutory determination process to formally classify their product(s).
Secondary information
- Type
- Written question
- Reference
- 49589
- Session
- 2016-17
- Subjects
- Licensing Drugs Medicines and Healthcare products Regulatory Agency Cannabidiol
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2016-10-28 11:24:13 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2016-17/49589
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2016-17/49589
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2016-17/49589